Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Skin inflammation can worsen intestinal inflammation and colitis.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

PRP treatment may help with alopecia areata, especially in newer cases.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

A new mouse model effectively mimics vitiligo for research and drug testing.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

New treatments focusing on immune pathways show promise for stubborn hair loss.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

New medications could improve treatment for severe alopecia areata in Australia.

Females generally have stronger immune responses than males due to the X chromosome.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Lung immune cells can be trained to better fight infections after a virus.

Probiotics show promise for health benefits but need more research to understand how they work.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.